Effect of subsequent passages on biofilm formation intensity, ALS genes expression, and cell surface hydrophobicity variability in clinical Candida albicans isolates Authors: Hasti Nouraei, Neda Amirzadeh, Shafigheh Shabanzadeh, Zahra Zareshahrabadi, Neda Shamsdin, Mohammad Nouraei, Behrouz Naeimi, Keyvan Pakshir Published: 2026 ABSTRACT AbstractCandida albicans is an opportunistic yeast pathogen that have several virulence factors included biofilm formation, cell surface hydrophobicity (CSH), and the expression of adhesion genes. Concerns exist that serial laboratory subculturing may diminish these traits, leading to inaccurate research findings. Aim of this study was evaluated the effect of subsequently subcultures on biofilm formation intensity, ALS gene expression, and surface hydrophobicity properties in clinical C. albicans isolates. Ten clinical C. albicans isolates were serially subcultured up to 20 passages (P). We used qPCR to quantify ALS1 and ALS3 gene expression, the Crystal Violet assay to measure biofilm formation intensity (P1, P5, P10, P15, P20), and a water-octane partitioning assay for CSH variability at different passages. Serial subculturing caused gradual downregulation of gene expression for both ALS1 and ALS3 (p < 0.001). This condition was accompanied by a biofilm-forming capacity that became progressively reduced in 90% of isolates, whereas 60% at P20 were already biofilm-negative (vs. 10% at P1). Cell surface hydrophobicity also decreased progressively, with 100% of isolates displaying low CSH at P15, compared with 40% in the initial P1 state. Serial subculturing leads to a rapid reduction of C. albicans pathogenic fitness with decreased expression of certain key adhesion genes, diminished biofilm formation, and lower CSH. These results highlight the plasticity of the organism and thus strongly suggest that low-passage clinical isolates should be used in studies to reflect true pathogenicity in vivo accurately.Keywords: ALS gene expression, Cell surface hydrophobicity, Biofilm formation, Serial subcultures, Candida albicansSubject terms: Microbiology, Molecular biology Introduction Fungal infections represent a significant and growing concern for public health around the world1,2. Among fungal diseases, invasive candidiasis is one of the most significant fungal infections induced by Candida species3. The opportunistic yeasts of the Candida genus account for nearly 90% of these infections and are the fourth most prevalent cause of nosocomial bloodstream infections4–6. There are over 150 different species in this genus, even though just a limited number of these are recognized as pathogenic to both humans and animals7. Among these, C. albicans emerges as the predominant opportunistic pathogen, colonizing both healthy individuals as commensals and immunocompromised hosts as an invasive agent. It is responsible for more than 80% of all human candidiasis cases6,7. This ability to switch from commensal to pathogen is a key feature of its virulence. C. albicans can increase its ability to invade by presenting several infectiousness factors like hydrophilic properties, biofilm development, ergosterol content, secreting enzymes, and fitness attributes8,9. The cell surface hydrophobicity of C. albicans and its capacity for biofilm production are critical for irreversible attachment to the host surface before invasion10,11. Biofilm can create the barriers that inhibit antifungal penetration, resulting in increased drug resistance. The National Institutes of Health recently has suggested that pathogenic biofilms are involved in more than 80% of all microbial infections, either directly or indirectly12. A major challenge in the candidiasis management is therapeutic failure, mainly because of clinical antifungal resistance13. C. albicans typically forms larger and more complex biofilms compared to the other Candida species. The structure of C. albicans biofilms is more varied because they are made up of many types of yeast-form cells, such as round budding cells, oval-shaped, pseudohyphal cells, and prolonged hyphal cells, which are surrounded by an extracellular matrix (ECM) that protects them from physical and chemical damage14–16. Moreover, a multitude of genes, including ALS, ECE, HWP, HYR, RBT5, and ECM, regulating adhesion, hyphal development, extracellular polymer substances (EPSs) synthesis, proliferation, maturation, and dissemination modulate biofilm formation6,17. Among these, the ALS (Agglutinin-Like Sequence) gene belongs to a family of fungal cell surface glycoproteins that are involved in cell adhesion and attaching to different types of cell surfaces18. There are several genes in the ALS gene family, such as the ALS1-ALS7 and ALS9 genes, that help make glycoproteins on the surface of cells, which makes them more sticky to host cells17,19. Adherence to the host endothelium and epithelium cells is influenced by the ALS1 and ALS3 genes17,20. Cell surface hydrophobicity (CSH), which enhances cell adherence to surfaces, is another characteristic that can influence adhesive properties; however, it differs among species21. Prior research has demonstrated a positive relationship between CSH and Candida adherence to the inert polymeric substrate and mucosal epithelial cells22. To determine the pathogenicity factors of fungi, multiple assays must be done over time. A major methodological limitation is the necessity for serial subculturing of clinical isolates, spanning from primary isolation to additional diagnostics. It remains unclear whether repeated passaging cause’s virulence attenuation to an extent that introduces a confounding variable, potentially undermining the validity of pathogenicity assessments. Performing different passages on the species can lead to the occurrence of changes in the virulence and potency of the pathogenicity of these disease-causing agents, thereby complicating the assessment results. Consequently, comprehending how successive subcultures influence ALS gene expression, biofilm formation intensity, and cell surface hydrophobicity is essential for clarifying the pathogenic mechanisms of C. albicans and developing effective therapeutic strategies. This study aimed to investigate the impact of successive subcultures on biofilm formation, ALS gene expression, and cell surface hydrophobic characteristics in clinical isolates of C. albicans. To our knowledge, this is the first integrated assessment of serial subculturing effects on ALS gene expression, biofilm formation, and cell surface hydrophobicity in clinical C. albicans isolates across 20 passages in Iran, and providing novel insights into the rate, heterogeneity, and mechanistic dissociation of passage‑induced virulence attenuation. Result Effect of serial subculturing on ALS1 and ALS3 gene expression Our analysis showed a general trend of downregulation of both ALS1 and ALS3 gene expression as subculture passages progressed, although such downregulation varied in magnitude among isolates. A prominent and progressive decrease in ALS1 gene expression was seen in all isolates. For instance, isolate 1 showed a fold change of 0.400 at P10, which further decreased to 0.200 at P20. Isolate 2 had a fold change of 0.500 at P10 and 0.250 at P20. Most isolates demonstrated this general trend of progressive reduction; however isolate 5 showed a greater level of downregulation with fold changes of 0.300 at P10 and 0.150 at P20. This result indicates that there is a clear trend towards reduced expression of ALS1 after being serially subcultured, while there were distinctions in the amount of reduction among each individual strain (p < 0.001). For ALS3 gene expression also, there was overall downregulation among the isolates. Isolate 1 had a fold change of 0.465 at P10 and 0.230 at P20. Isolate 2 had a fold change of 0.450 at P10 and 0.220 at P20. Other isolates also showed a progressive down regulation of ALS3 expression. Isolate 5 again showed a greater level of reduction with fold changes of 0.350 at P10 and 0.180 at P20 (p < 0.001). These quantitative changes show a consistent and progressive trend of reduced expression of ALS1 and ALS3 along with increased passages while demonstrating the normal biological variability among clinical isolates (Table 1). Table 1The specific primer sequences and PCR product length.GenesPrimer sequence (5′→3′)Size (bp)Annealing (°C)ALS1F CTGTAACCACGTTCAGAC20954R CCAGCTTTCTACGTTTCCALS3F CCAAGTGTTCCAACAACTGAA18457R GAACCGGTTGTTGCTATGGTACT1F ACTACCATGTTCCCAGGTATTG12255R CCACCAATCCAGACAGAGTATT The specific primer sequences and PCR product length. Effect of serial subculturing on biofilm formation intensity Serial passages considerably influenced biofilm formation capacity. A clear progressive decrease in biofilm intensity was observed in 9 out of 10 isolates (90%) from P1 to P20 (Table 2). In contrast, one isolate was constantly biofilm-negative through all passages. No isolate ever showed an increase in intensity of biofilm production. Such decreases were typically observed from a range of high to low or negative intensity (Table 2). Table 2Details of biofilm formation and cell surface hydrophobicity in all isolates during 20th subculture.Code NumberCHSBiofilm FormationPassage 1Passage 5Passage 10Passage 15Passage 20Passage 1Passage 5Passage 10Passage 15Passage 201LowLowLowLowLowModeratelyModeratelyMildlyNegativeNegative2ModerateModerateLowLowLowNegativeNegativeNegativeNegativeNegative3ModerateLowLowLowLowIntenselyIntenselyIntenselyModeratelyModerately4LowModerateModerateLowLowMildlyNegativeNegativeNegativeNegative5ModerateModerateLowLowLowIntenselyIntenselyModeratelyModeratelyModerately6ModerateModerateLowLowLowModeratelyModeratelyModeratelyModeratelyMildly7ModerateModerateModerateLowLowMildlyMildlyMildlyMildlyNegative8LowLowLowLowLowModeratelyModeratelyModeratelyMildlyMildly9ModerateLowLowLowLowModeratelyMildlyMildlyMildlyNegative10LowLowLowLowLowMildlyMildlyNegativeNegativeNegative Details of biofilm formation and cell surface hydrophobicity in all isolates during 20th subculture. Overall, at P1, 10% of isolates were negative, 30% mild, 40% moderate, and 20% intense biofilm producers. By P5, the distribution changed to 0% negative, 20% mild, 30% moderate, and intense for 20% isolates. At P10, this range was 30% negative, 30% mild, 30% moderate, and 10% intense. By P15, the results changed to 40% negative, 30% mild, and 30% moderate, with 0% intense. By P20, nearly 60% of the isolates were negative, 20% mild, and 20% moderate, and no intense ones were observed. Effect of serial subculturing on cell surface hydrophobicity variability Cell surface hydrophobicity changed significantly with serial subculturing. A general decrease ranging from moderate CSH to low was observed in 6 of the 10 isolates (60%) (Table 2). A transitory increase to moderate CSH was noted in case one isolate at passages P5 and P10, and then it reverted back to low CSH at P15 and P20, thus showing a net decrease when compared to P1. Three other isolates (30%) showed low CSH consistently throughout all passages (Table 2). Importantly, under the experimental conditions used, none of the isolates showed a sustained increase in CSH. The dominant trend turns out to be a general decrease of cell surface hydrophobicity versus time in vitro. Overall, at passage 1, 40% of isolates showed low CSH, while the rest showed moderate CSH. By P5, half of the isolates showed low CSH, whereas the other half showed moderate CSH. At P10, the picture had changed somewhat, with 80% of isolates displaying low CSH and only 20% maintaining moderate CSH. This would continue to P15 and P20, when all isolates would show low CSH, whereas none would show moderate CSH (Table 2). This indicates a progressive decrease in the proportion of isolates exhibiting moderate hydrophobicity and a corresponding increase in low hydrophobicity, with prolonged subculturing. Relationship between biofilm formation and cell surface hydrophobicity Analysis of the relationship between biofilm formation and cell surface hydrophobicity (CSH) revealed a complex interplay. For five of the ten biofilm producers there was a positive decrease in CSH associated with, or preceding, the decrease in biofilm formation. There were major exceptions, with three of the ten isolates (30%) revealing a decrease in biofilm formation while maintaining consistently low CSH for all passages, suggesting a mechanism of reduction unrelated to changes in biofilm surface hydrophobicity. In addition, one isolate (10%) exhibited diminished biofilm formation with also variable CSH levels, thus rationalizing that not all correlations were linear. Another isolate (10%) decreased in CSH but never increased in detectable biofilm attachment. These results demonstrate the notable observation that while a decrease in CSH is noted in conjunction with biofilm attenuation, especially for isolates initially exhibiting moderate hydrophobicity, loss of biofilm-forming capacity can also be path independent of CSH in C. albicans clinical isolates with serial subculturing. Discussion This study focused on both the phenotypic and genotypic variability of clinical C. albicans isolates following extensive serial subculturing in vitro. In our results, what emerged was a notable, stepwise reduction in virulence-related traits, such as significant downregulation of adhesion genes (ALS1, ALS3), a shrinking ability to form biofilms, and a measurable decrease in cell surface hydrophobicity, which could influence real adherence ability. In summary, repeated subculturing in artificial, nutrient-rich media without the selective pressures present inside a host resulted in a clear loss of pathogenic fitness in these clinical isolates. One of the most remarkable results was the consistent and progressive drop in both ALS1 and ALS3 expression across all isolates tested. The fold change reduction, often exceeding 50% by the 20th passage, indicates a substantial decline in the transcriptional activity of these critical adhesion genes. This suggests a real adaptive shift: in the absence of host-like stress, C. albicans appears to downregulate genes that aren’t crucial for survival in the lab. There could be a metabolic trade-off, as virulence factors are energetically expensive to make if not required23. This confirms previous observations of rapid adaptive evolution and microevolution processes occurring during in vitro passaging, resulting in a slow decrease in virulence with time24. It implies very strongly that use of strains that have been subjected to many passages in the laboratory might inadvertently select for phenotypes that do not faithfully represent the behavior of C. albicans during an actual infection. For studies aiming to capture in vivo pathogenicity, minimum passage of clinical isolates remains essential. The circumstances differ when they are replicating in the body as normal flora or causing an infection, because in the latter case, they are in contact with immune cells and other host resistance factors, while these factors are not present in laboratory conditions. Corresponding to the decreased adhesion gene expression, we also observed a critical phenotypic change like intensity reduction of progressive biofilm formation in 90% of isolates. This highlights the dynamic nature of C. albicans virulence and its environmental signal regulation. The strong correlation between down-regulation of ALS1/ALS3 expression and diminishing biomass biofilm is mechanistically reasonable, as Als1p and Als3p have a central role to play in cell-surface and cell–cell adhesion during biofilm formation25,26. The loss of strong biofilm-forming ability following serial passage is of serious implication, suggesting that prolonged culture in the laboratory might impose selection for phenotypes being poor at strong surface colonization. This could have implications for the external validity of experimental findings since experimental studies using high-passage strains could result in an underestimation of the true biofilm-forming ability and antifungal resistance profile of C. albicans during acute infection12,27. In the same vein, the substantial reduction of cell surface hydrophobicity induced by multiple passaging is a more direct indicator of a phenotypic adaptation. Cell surface hydrophobicity (CSH) is crucial for the ability to attach to a host surface for the very first step of colonization28,29. If there were to be a decrease in CSH, this would signal a decreased capacity to adhere to the host surface in the initial colonization steps. CSH is mostly dependent upon the composition of the cell wall, specifically hydrophobic proteins and certain fractions of phosphomannoproteins30. The reduction that we observed indicates that the simplified laboratory environment is creating changes in cell wall composition or structure, potentially by changing glycosylation or altering the expression of certain proteins; however, the conditions inside the body might be different. A phenotypic change that is linked to potential underlying cellular mechanisms for adaptation in response to the environmental signals: the findings demonstrate that C. albicans surface properties are flexible based on environmental cues24,31. The correlations observed between these traits under the pressure of serial subculturing reveal a complex interplay. Half the isolates had their CSH and biofilm formation concurrently decreased; in another sizable subset (30%), however, the fungus lost its capacity to form biofilm while maintaining consistently low CSH, indicating that attenuation could occur through mechanisms independent of gross hydrophobicity changes. This complexity further highlights the amazing ability of this organism to adapt. Being able to keep virulence going along another path, maybe via upregulation of other genes that were not measured in this study or increased production of the extracellular matrix, is yet another adaptive strategy developed by C. albicans even without selective pressure from the host. Several biological factors beyond the measured parameters may have contributed to the observed passage‑induced attenuation32. Although we documented progressive downregulation of ALS1 and ALS3, associated decreases in biofilm formation and CSH could also be influenced by unmeasured changes in overall growth rate, cellular fitness, or morphological plasticity. Serial subculturing in nutrient‑rich laboratory media may select for variants with accelerated growth or reduced filamentation capacity, both of which would independently reduce biofilm formation regardless of ALS expression levels33. Notable heterogeneity was observed among the ten clinical isolates in their response to serial subculturing. While most isolates showed progressive attenuation of biofilm formation and CSH, the rate and magnitude of decline varied considerably. For example, isolate one isolate retained intense biofilm formation through P10 and remained moderately positive even at P20, whereas another isolate shifted from mildly positive at P1 to negative by P5 and stayed negative thereafter. Similarly, CSH decreased from moderate to low in six isolates by P15, but four isolates already exhibited low CSH from P1 onward. This inter‑isolate variability likely reflects underlying genetic differences in regulatory pathways main adhesion and biofilm formation. It also suggests that some strains are stronger to passage‑induced attenuation, possibly due to inherent differences in baseline virulence gene expression or metabolic fitness. This study demonstrates that when using fungal stocks from in vitro conditions to assess the pathogenicity of isolates, their true pathogenic potential cannot be accurately evaluated after serial passages. However, the conditions within a host organism are fundamentally different, a distinction that requires further investigation. Whether serial passage in liquid media produces similar or distinct attenuation patterns remains an open question and warrants further investigation, as liquid culture may impose different selective pressures compared to solid agar. A fundamental limitation of this study is that all experiments were conducted entirely in vitro, using standard laboratory media and abiotic polystyrene surfaces. While this approach enabled controlled, reproducible assessment of serial passage effects on specific virulence traits, it does not replicate the complex selective pressures present during natural infection (e.g., immune cells, competing microbiota, fluctuating nutrients, and host tissue surfaces), all of which can modulate gene expression, biofilm formation, and phenotypic switching. Furthermore, we focused on only two adhesion genes (ALS1 and ALS3), whereas the biofilm regulatory network is considerably more complex, involving genes such as HWP1 and ECE1. Future transcriptomic studies (e.g., RNA‑Seq) could provide a global perspective on adaptive changes, and examining other virulence traits (e.g., secreted enzyme activity, morphotypic switching) would offer a more complete picture. Finally, we did not measure other potential confounders such as changes in growth rate, overall fitness, or hyphal formation efficiency during serial passaging. Serial subculturing could select for variants with accelerated growth or reduced filamentation capacity, which would independently reduce biofilm formation regardless of ALS expression levels. Although our gene expression data point to a key role for Als1/Als3, future work should integrate growth kinetics and morphotypic analysis to fully dissect the mechanisms of passage‑induced attenuation. Conclusion Our findings demonstrate that serial subculturing of clinical C. albicans isolates results in a progressive loss of pathogenic potential. The ability to attenuate in vitro has important pragmatic implications, advocating strongly for future research to conduct studies with low-passage clinical isolates to maintain accuracy and relevance. From a broader perspective, our observations about the acquired loss of virulence point towards the remarkable plasticity of C. albicans. Serial subculture of stocked isolates can lead to reduced pathogenicity, which may account for divergent experimental results. However, because our experiments were conducted entirely in vitro, further studies using animal models are required to determine whether similar attenuation occurs under host‑relevant conditions. Materials and methods Isolates and subculturing Ten clinical Candida albicans isolates were obtained from the mycology reference collection of the Department of Parasitology and Mycology, Shiraz University of Medical Sciences. These isolates were originally recovered from patients attending affiliated teaching hospitals (Shiraz, Iran). All isolates were identified by using standard mycological methods (germ tube test, CHROMagar Candida, and PCR amplification of species-specific primers), as detailed in our previous work30,34. All isolates had been stored long‑term at − 20 °C in Sabouraud Dextrose Broth containing 20% glycerol. Their exact subculture history prior to storage is unknown, as they were obtained from a routine diagnostic reference collection. For preparation, isolates were initially cultured on Sabouraud Dextrose Agar (SDA). Each isolate was serially subcultured up to 20 passages (P). For revival, each frozen stock was streaked onto SDA and incubated at 32 °C for 24 h (designated Passage 0, P0). A single colony from P0 was then subcultured onto fresh SDA to obtain Passage 1 (P1). This process was repeated sequentially up to Passage 20 (P20). For each passage of interest (P1, P5, P10, P15, P20), a single colony was inoculated into Yeast Peptone Dextrose broth, grown overnight at 32 °C, harvested by centrifugation, washed, and standardized to the required cell density for biofilm formation, cell surface hydrophobicity, and RNA extraction. All assays for a given passage were performed in parallel on the same day. To ensure no cross-contamination, colony morphology was monitored at each passage, and random P20 isolates were re-identified as C. albicans using CHROMagar and germ tube testing. The passage number directly indicates the number of prior subcultures on SDA, with no additional subcultures between the passage plate and the assay. Changes in ALS gene expression were evaluated at sequential passages of 1st (P1), 10th (P10), and 20th (P20). Additionally, changes in biofilm formation intensity and cell surface hydrophobicity properties were assessed at P1, P5, P10, P15, and P20. Figure 1. Throughout the 20 serial passages, all isolates retained their original species identity as C. albicans, as confirmed by germ tube formation, and CHROMagar growth at P10 and P20. No cross‑contamination or strain switching was detected, and the changed in ALS expression, biofilm formation, and CSH therefore represent phenotypic adaptation rather than loss of the original strain. Experimental workflow for evaluating sequential passage effects on Candida albicans isolates. Gene expression analysis by quantitative RT-PCR The expressions of ALS135 and ALS335 genes were quantified in each individual C. albicans clinical isolate throughout serial subcultures (P1: first passage, P10: 10th passage, P20: 20th passage) according to the comparative Ct method (ΔΔCt). The first passage (P1) was used as the control, with its relative expression arbitrarily set at 1.000 for both ALS1 and ALS3 genes for each isolate, and the ACT136 gene was used as Candida housekeeping gene. Methodology context for gene expression measurement A highly sensitive method for quantifying messenger RNA (mRNA) levels is quantitative polymerase chain reaction (qPCR). Thereby, total mRNA was extracted from C. albicans isolates during various subculture passages using the SinaPure Kit (Sinuhe Biotech, Iran). Complementary DNA (cDNA) was synthesized using reverse transcriptase for each passaged sample in a two-part protocol with a cDNA synthesis kit (Sinuhe Biotech Company) and completely according to the indicated detailed process. Specific primers for ALS1 and ALS3 were used (Table 1), and expression was normalized to the ACT1 housekeeping gene. The RT-PCR reaction mixture (25 µl final volume) contained 2 µl cDNA, 1 µl each of the forward and reverse primers (for each target gene), 12.5 µl Master Mix SyberGreen Low Rox, and 8.5 µl sterile distilled water. Amplification was performed using the following thermal cycling protocol on the QuantStudio 5 (ABI, USA): initial denaturation at 95 °C for 10 min (1 cycle), followed by 40 cycles of denaturation at 95 °C for 10 s, primer annealing at gene-specific temperatures (Table 1) for 30 s, and extension at 72 °C for 30 s, with a final dissociation step at 95 °C for 15 s. Following amplification, melt curve analysis was conducted on the same instrument to verify PCR product specificity (Table 3). Table 3Standardized experimental conditions used throughout the study.ParameterSubculturingOvernight cultureBiofilm formationCell surface hydrophobicityGene expression (qPCR)Medium / SubstrateSabouraud Dextrose AgarYeast Peptone Dextrose brothYeast Nitrogen Base mediumPBS + octaneYPD for growth; RNA extraction kitTemperature32 °C32 °C37 °CRoom temperatureGene-specific annealingIncubation time24 h16–18 h (overnight)Adhesion:1.5 h; Maturation: 66 h15 min (phase separation)Not applicable (thermal cycling)Cell densitySingle colony (streaked)Starting from a single colony1 × 10⁷ cells/mL1 × 108 cells/mL1 × 108 cells/mLReading / detectionVisual (colony morphology)Visual (turbidity)OD₅₇₀ nm after crystal violet stainingOD₆₀₀ nm (aqueous phase)Ct values (SYBR Green) Standardized experimental conditions used throughout the study. Biofilm formation quantification Biofilm formation in C. albicans isolates across serial subcultures (P1, P5, P10, P15, and P20) was quantified by the Crystal Violet (CV) assay to measure total biofilm biomass. The production of biofilm was conducted utilizing a modified microtiter plate assay derived from the methodologies of Jin et al.37 and Melo et al.38. Briefly, 100 μl of a standardized Candida spp. cell suspension (1 × 10⁷ cells/mL) was put into wells of flat-bottom 96-well microtiter plates. Eight wells without Candida spp. served as negative controls. To help the cells stick, the plates were incubated at 37 °C with shaking (75 rpm) for 1.5 h. After adhesion, the supernatant was gently aspirated to get rid of non-adherent cells, and each well was washed twice with 150 μl of PBS. Then, 100 μl of Yeast Nitrogen Base (YNB) medium with 50 μM D-glucose monohydrate was added to each well. The plates were then shaken (75 rpm) at 37 °C for 66 h to let biofilm grow. After incubation, the medium was sucked out, and mature biofilms were washed twice with 150 μl PBS to obtain rid of any cells that weren’t stuck to the surface and any leftover medium. The plates were washed and then left to dry in the air for 15 to 30 min. After that, biofilms were stained with 110 µl of 0.4% (w/v) aqueous crystal violet solution for 45 min at room temperature. Excess stain was removed by thorough washing with distilled water. Adding 150 µl of 95% ethanol to each well for 10 to 15 min dissolved the bound crystal violet. The optical density (OD) of the solubilized crystal violet solution was measured at 570 nm using a BMG LABTECH microplate reader (Table 3). Biofilm formation was categorized based on optical density cut-off values (ODc). These values are the mean OD of negative control wells (ODnc) plus three times its standard deviation (ODc = ODnc_mean + 3 × SDnc) [19]. The following categories were given: Negative: OD ≤ ODc Negative: OD ≤ ODc Mildly positive: ODc < OD ≤ 2 × ODc Mildly positive: ODc < OD ≤ 2 × ODc Moderately positive: 2 × ODc < OD ≤ 4 × ODc Moderately positive: 2 × ODc < OD ≤ 4 × ODc Intensely positive: OD > 4 × ODc Intensely positive: OD > 4 × ODc All assays were performed in triplicate for each isolate39. Cell surface hydrophobicity measurement Cell surface hydrophobicity (CSH) was determined using a water-octane two-phase partitioning assay40. To separate the phases, 1.2 mL of washed yeast cell suspensions (adjusted to 1 × 10⁸ cells/mL in phosphate-buffered saline, PBS) were mixed with 0.3 mL of octane and left at room temperature for 15 min (Table 3). The negative control comprised 1.2 mL of cell suspension devoid of octane. For both the control (A_control) and the octane-treated sample (A_sample), the absorbance of the aqueous phase at 600 nm (A₆₀₀) was measured. CSH was calculated as the percentage of cells partitioning out of the aqueous phase using the formula: Hydrophobicity levels were categorized as follows based on established criteria [18]: High CSH: 80% ≤ CSH ≤ 100% High CSH: 80% ≤ CSH ≤ 100% Moderate CSH: 20% ≤ CSH < 80% Moderate CSH: 20% ≤ CSH < 80% Low CSH: 0% ≤ CSH < 20% Low CSH: 0% ≤ CSH < 20% Statistical analysis For data analysis, SPSS software (version 24, USA) was used, and the statistical significance level was considered at a p value ≤ 0.05. Given the small sample size the non‑normal distribution of the data, non‑parametric tests were employed throughout. Also, descriptive statistics analysis methods, the Mann–Whitney test, and the Wilcoxon test were used for gene expression. The RT-PCR results were analyzed to investigate the differences in the expressions of the, ALS1 and ALS3 genes using the 2−ΔΔ CT formula and GraphPad Prism software (version 8). Using the 2−ΔΔ CT formula, the fold changes in the expressions of the mentioned genes were determined by comparing the observed differences in the ΔΔCT values. Because the same ten isolates were measured repeatedly across different passages (P1, P10, P20 for gene expression; P1, P5, P10, P15, P20 for biofilm and CSH), the data have a repeated‑measures structure observations from the same isolate are not independent. Therefore, the Friedman test was used for comparisons across three or more time points. Post-hoc pairwise comparisons were performed using the Wilcoxon signed‑rank test with Bonferroni correction to account for multiple comparisons. Acknowledgements The data of this study was financially supported by the Vice-Chancellor for Research of Shiraz University of Medical Sciences grant no. 32536. This work is based upon research funded by Iran National Science Foundation (INSF) under project No. 4040905. Author contributions Hasti Nouraei: Methodology; Formal Analysis, Investigation; Writing—original draft preparation; Writing—review and editing, Neda Amirzadeh, Mohammad Nouraei and Behrouz Naeimi: Investigation, Shafigheh Shabanzadeh: Methodology; Writing—original draft preparation, Zahra Zareshahrabadi and Neda Shamsdin: Methodology, Keyvan Pakshir: Conceptualization; Methodology; Funding acquisition; Resources; Supervision; Project Administration; Validation; Visualization; Writing—original draft preparation; Writing—review and editing. Funding This work was financially supported by the Vice-Chancellor for Research of Shiraz University of Medical Sciences [Grant Numbers. 32536]. Data availability The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Competing interests The authors declare no conflict of interest. Ethics approval This project was found to be in accordance to the ethical principles and the national norms and standards for conducting Medical Research in Iran and has been approved by (The Research Ethics Committees of Shiraz University of Medical Sciences, Iran. IR.SUMS.REC.1404.134). Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.